Delivery Order SPE2DX22D0099-SPE2D825FAQ5E

The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,724.91 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on August 4, 2025, with completion by August 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured without set-aside designation and involves pharmaceutical and medical supply products to support federal healthcare operations. The work will be performed at the contractor's corporate office location in Conshohocken, PA.

This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical support agreement with the Defense Logistics Agency, which includes a primary IDC valued at $999,999,999.00 and extending through December 2026. The company's federal contract portfolio demonstrates its role as a critical vendor for military and veteran healthcare systems, supplying an extensive range of products including brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical utilizes such prime vendor contracts to ensure flexible and efficient pharmaceutical supply chain management for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.